Miscellaneous Analgesics

Ahmed S. S. , Potentiation of the Analgesic Effect of Codeine in Rats by D-Amphetamine, Arch. Internal Pharmacodyn. 159: 185–8 (Jan.) 1966. (OA).

Anon.: AMA Drug Evaluations, 1st ed., American Medical Association, Chicago, 1971.

Antlitz A. M. , Potentiation of Oral Anticoagulant Therapy by Acetaminophen, Current Therap. Res. 10: 501 (Oct.) 1968. (OH).

Antlitz A. M. Await L. F. : A Double Blind Study of Acetaminophen Used in Conjunction with Oral Anticoagulant Therapy, Current Therap. Res. 11: 360 (June) 1969. (OH).

Antonita Sister M. : Necessary Precautions When Dispensing Oral Progestational Drugs to Inpatients, Hosp. Formulary Management 3: 34 (Feb.) 1968. (R).

Brownlee G. Williams G. W. : Potentiation of Amphetamine and Pethidine by Monoamine Oxidase Inhibitors (Letters), Lancet 1: 669, (Mar. 23) 1963. (AO).

Carter S. A. : Potentiation of the Effect of Orally Administered Anticoagulants by Phenyramidol Hydrochloride, New Engl. J. Med. 273: 423–6 (Aug. 19) 1965. (OCH).

Christensen E. M. Gross E. G. : Analgesic Effects in Human Subjects of Morphine, Meperidine, and Methadone, J. Am. Med. Assoc. 137: 594 (June 12) 1948. (OH).

Churchill-Davidson H. C. : Anaesthesia and Monoamine Oxidase Inhibitors (Letters), Brit. Med. J. 1: 520 (Feb. 20) 1965. (CHO).

Conney A. H. , Effects of Pesticides on Drug and Steroid Metabolism, Clin. Pharmacol. Therap. 8: 2 (Jan.-Feb.) 1967. (OA).

Contreras E. Tamayo L. : Effects of Drugs Acting in Relations to Sympathetic Functions of the Analgesic Action of Morphine, Arch. Intern. Pharmacodyn. 160: 312 (Apr.) 1966. (OA).

Eade N. R. Renton K. W. : Effect of Monoamine Oxidase Inhibitors on the N-Demethylation and Hydrolysis of Meperidine, Biochem. Pharmacol. 19: 2243 (July) 1970. (OA).

Elking Sister M. P. Rabat H. F. : Drug Induced Modifications of Laboratory Test Values, Am. J. Hosp. Pharm. 25: 485 (Sept.) 1968. (R).

Garb S. : Clinical Guide to Undesirable Drug Interactions and Interference, 1st ed., Springer Publishing Co. Inc. N.Y. 1970.

Goodman L. S. Gilman A. : The Pharmacological Basis of Therapeutics, 4th ed., Macmillan, N.Y., 1970 a – p. 245, b – p. 258, c – p. 320, d – p. 324, e – p. 330, f – p. 331, g – p. 332, h – p. 337, i – p. 338, j p. 340.

Grotto M. , Additive and Augmentative Synergism Between Analgesic Drugs, Arch. Intern. Pharmacodyn. 155: 365–72 (June) 1965. (OA).

Hansten P. D. : Drug Interactions, 1st ed., Lea & Febiger, Phila., 1971.

Hoffbrand B. I. Kininmonth D. A. : Potentiation of Anticoagulants, Brit. Med. J. 2: 838–9 (June 24) 1967. (CH).

Hussar D. A. : Tabular Compilation of Drug Interaction, Am. J. Pharm. 141: 107, 1969. (R).

Jeremy R. Towson J. : Interaction Between Aspirin and Indomethacin in the Treatment of Rheumatoid Arthritis, Med. J. Australia 2: 127 (July 18) 1970.

Kampfmeyer H. G. , Failure to Detect Increased Elimination Rate of Phenacetin in Man after Treatment with Phenobarbital, Klin. Wochschr. 47: 1237 (Oct.) 1969.

Keats A. S. Telford J. Kurosu Y. : Potentiation of Meperidine by Promethazine, Anesthesiology 22: 34 (Jan.-Feb.) 1961. (OH).

King T. M. Burgard J. K. : Drug Interactions, Am. J. Obstet. Gynecol. 98: 128 (May 1) 1967. (R).

Levy G. Procknal J. A. : Drug Biotransformation Interaction in Man 1. Mutual Inhibition in Glucuronide Formation of Salicylate Acid and Salicylamide in Man, J. Pharm. Sci. 57: 1330–1335 (Aug.) 1968. (OH).

Mielens Z. E. , Interaction of Aspirin with Nonsteroidal Anti-Inflammatory Drugs in Rats (Letters), J. Pharm. Pharmacol. 20: 567 (July) 1968. (OA).

Palmer H. : Potentiation of Pethidine, Brit. Med. J. 2: 944, 1960. (CH).

Papp C. Benamin S. : Toxic Effects of Iproniazid in a Patient with Angina, Brit. Med. J. 2: 1070 (Nov. 1) 1958. (CH).

Pearson R. E. Salter F. J. : Drug Interaction, Orphenadrine with Propoxyphene (Comment), New Engl. J. Med. 282: 1215 (May 21) 1970.

Puckett W. H. Visconti J. A. : Orphenadrine and Propoxyphene (Comment), New Engl. J. Med. 283: 544 (Sept. 3) 1970.

Renforth W. : Orphenadrine and Proxyphene, New Engl. J. Med. 283: 998 (Oct. 29) 1970. (CH).

Riesterer L. Jacques R. : Interference by β-Adrenergic Blocking Agents with the Anti-Inflammatory Action of Various Drugs, Helv. Physiol. Acta 26: 287, 1968.

Roche Literature; Matulane (Procarbazine HCl), August 1969.

Sellers E. M. Koch-Weser J. : Displacement of Warfarin from Human Albumin by Diazoxide and Ethacrynic, Mefenamic and Nalidixic Acids, Clin. Pharmacol. Therap. 11: 524 (July-Aug.) 1970. (OT).

Shee J. C. : Dangerous Potentiation of Pethidine by Iproniazid and Its Treatment, Brit. Med. J. 2: 507 (Aug. 13) 1960. (CH).

Skeith M. D. , The Renal Excretion of Indomethacin and Its Inhibition by Probenecid, Clin. Pharmacol. Therap. 9: 89 (Jan.-Feb.) 1968. (OH).

Slaughter D. Munsell D. W. : Some New Aspects of Morphine Action: Effects on Pain, J. Pharmacol. Exptl. Therap. 68: 104 (June) 1940. (OA).

Solomon H. M. Schrogie J. J. : The Effect of Phenyramidol on the Metabolism of Diphenylhydantoin, Clin. Pharmacol. Therap. 8: 554 (July-Aug.) 1967. (OH).

Udall J. A. : Drug Interference with Warfarin Therapy (abstr.), Am. J. Cardiol. 23: 143 (Jan.) 1969. (OH).

Vesell E. S. : Genetic Control of Phenobarbital Induced Shortening of Plasma Antipyrine Half-Life in Man, J. Clin. Invest. 48: 2202 (Dec.) 1965. (OH).

Wallis R. : Potentiation of Hypnotics and Analgesics: Clinical Experience with Chlorpromazine, N.Y. State J. Med. 55: 243 (Jan. 15) 1955. (H).

Webb D. I. , Mechanism of Vitamin B12 Malabsorption in Patients Receiving Colchicine, New Engl. J. Med. 279: 845–850 (Oct. 17) 1968. (OH).

Wiederholt I. C. , Recurrent Episodes of Hyperglycemia Induced by Propoxyphene, Neurology 17: 703 (July) 1967. (CH).